In patients of ACC (p = 9.9 × 10–4), CHOL (p = 4.1 × 10–2), KICH (p = 2.6 × 10–2), KIRP (p = 3.0 × 10–5), LGG (p = 7.9 × 10–8), LUAD (p = 7.7 × 10–3), MESO (p = 9.4 × 10–4), PRAD (p = 1.5 × 10–2), SARC (p = 4.3 × 10–2), SKCM (p = 1.9 × 10–2), and UCEC (p = 5.5 × 10–4), higher C1ORF112 expression is associated with a worse prognosis (Supplementary Figure S2). This evidence concerns the gene FIRRM and adrenal cortex carcinoma.